Thrombocytopenia Treatment options have become significantly better with surgical and antiplatelet treatment

 

Thrombocytopenia Treatment

Thrombocytopenia or also known as "hardening of the arteries" is a potentially serious but often ignored cardiovascular illness. When blood flow to the heart is decreased, it can eventually lead to a condition called "atherosclerosis." Atherosclerosis is considered a primary, or primary form of the disease. In milder forms of the illness, it can cause blood clots that deposit in the arteries. While thrombocytopenia can affect men and women of all ages, it is more common in middle-aged and older people. Symptoms of the condition include shortness of breath or fatigue, swelling in the legs, nausea and vomiting, weakness, and frequent urination.

Diagnosis of thrombocytopenia involves several tests, including blood tests, chest x-rays, and blood test results. The most common thrombocytopenia treatment is antiplatelet treatment and in more severe cases, surgery. There are some lifestyle changes that can help. For example, smokers should quit and dieters should cut down on their salt intake. A more common thrombocytopenia treatment option for this condition is non-steroidal anti-inflammatory drugs or NSAIDs. These medications are used to reduce inflammation. They work by reducing the amount of plaque that builds up in the arteries, thereby reducing the pressure.

Corticosteroids can also be used to treat thrombocytopenia. These steroids reduce inflammation by limiting the ability of the immune system to produce markers of inflammation. They are usually used as a short-term treatment. Long-term use is not recommended due to the increased risks of stroke and heart attack. Surgery is another thrombocytopenia treatment option. If thrombocytopenia is diagnosed in one or both legs, a hip-replacement procedure may be needed. This procedure replaces a damaged or deformable part of the hip joint. It can fix the problem of thrombocytopenia in many cases. Laser surgery and surgical treatments are also options available. In laser surgery, the clot is removed by a specialist. The specialist will use a laser beam instrument to remove the clot. In April 2018, the U.S. Food and Drug Administration (FDA) approved Fostamatinib disodium hexahydrate (Tavalisse) as a second-line treatment for thrombocytopenia in adults with chronic immune thrombocytopenia (ITP).


Comments

Popular posts from this blog

Light Linear Alpha Olefins Are Produces through Oligomerization of Ethylene and by Fischer-Tropsch Synthesis

Cervical Cancer Diagnostic Tests have become highly sophisticated with accurate diagnosis for effective treatment

Beta Glucan-based products have been shown to be effective in lowering cholesterol and preventing heart disease